The following article points to other articles, which review some of the lifestyle modifications patients on the Marshall Protocol (MP) make in order to have a successful treatment outcome.
Marshall Protocol (MP) patients who are photosensitive must limit their exposure to light. This article summarizes information related to light restriction for MP patients. In later stages of the MP and/or when the treatment is complete, veterans of the MP may choose to expose their eyes and skin to increasing amounts of light.
For Marshall Protocol (MP) patients, the choice to exert oneself through physical activity or exercise should be made in the light of the stage of one's disease and the effect that extra activity has on the immune system. In different patients under different circumstances, exercise is capable of either suppressing or increasing the immune response.
MP patients who can perform their activities of daily living while recovering on the MP are as fit as they need to be. Their focus should be in regaining their health with the MP. With improved health will come improved abilty to exercise and increase endurance.
Traveling and participating in outdoor activities present several challenges unique to patients with Th1 disease. For those Marshall Protocol (MP) patients who are photosensitive, the most significant of these is the need to limit their exposure to light. Patients who suffer from cardiac, neurological, or respiratory inflammation put themselves at grave risk when exposing themselves to significant amounts of sunlight. The best way to see how one's body reacts to light is to increase exposure gradually.
Contingency planning such as taking of an extra olmesartan (Benicar) ahead of time can sometimes, though certainly not always, mitigate the harmful effects of excess sunlight.
Another consideration for going out is the need to avoid consumption of vitamin D in food.
One of the commonly reported symptoms among patients with chronic inflammatory diseases is cognitive dysfunction. For these people, there are two significant challenges to succeeding on the Marshall Protocol (MP): monitoring changes in symptoms and keeping track of when to take the next dose of MP medications, be they olmesartan or antibiotics. There are a number of tools available to do both.